Renaissance Technologies’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-7,089,144
Closed -$1.26B 3944
2020
Q1
$1.26B Buy
7,089,144
+2,069,332
+41% +$390M 1.22% 6
2019
Q4
$960M Buy
5,019,812
+1,345,644
+37% +$243M 0.74% 13
2019
Q3
$618M Buy
3,674,168
+930,202
+34% +$152M 0.52% 22
2019
Q2
$459M Buy
2,743,966
+485,600
+22% +$67.2M 0.4% 40
2019
Q1
$331M Buy
2,258,366
+448,231
+25% +$65M 0.3% 57
2018
Q4
$242M Buy
1,810,135
+804,106
+80% +$132M 0.26% 69
2018
Q3
$192M Buy
1,006,029
+218,201
+28% +$40.1M 0.2% 102
2018
Q2
$131M Buy
787,828
+784,928
+27,066% +$126M 0.14% 147
2018
Q1
$488K Sell
2,900
-723,369
-100% -$121M ﹤0.01% 2923
2017
Q4
$119M Buy
726,269
+663,100
+1,050% +$119M 0.13% 153
2017
Q3
$12.9M Sell
63,169
-171,000
-73% -$39.8M 0.02% 1172
2017
Q2
$56.9M Sell
234,169
-285,900
-55% -$67.2M 0.07% 333
2017
Q1
$124M Buy
+520,069
New +$121M 0.17% 116
2016
Q1
Sell
-206,701
Closed -$64.6M 3608
2015
Q4
$64.6M Buy
206,701
+152,732
+283% +$45.5M 0.14% 148
2015
Q3
$14.7M Buy
+53,969
New +$16.6M 0.04% 677
2015
Q1
Sell
-454,162
Closed -$117M 3423
2014
Q4
$117M Buy
454,162
+326,000
+254% +$81.5M 0.28% 43
2014
Q3
$30.9M Sell
128,162
-379,563
-75% -$84.9M 0.08% 286
2014
Q2
$113M Buy
507,725
+105,789
+26% +$21.9M 0.26% 57
2014
Q1
$82.7M Buy
401,936
+204,311
+103% +$40.5M 0.2% 83
2013
Q4
$33.2M Buy
+197,625
New +$30.9M 0.08% 292
2013
Q3
Sell
-13,864
Closed -$1.75M 3009
2013
Q2
$1.75M Buy
+13,864
New +$1.57M ﹤0.01% 1653

Other funds holding AGN

Renaissance Technologies's AGN Position: Q2 2020 in Review

Renaissance Technologies sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,089,144 shares — an estimated $1.26B sold.

Renaissance Technologies first reported a position in AGN in Q2 2013 and held it in 21 quarters. The position peaked at $1.26B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Renaissance Technologies reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Renaissance Technologies sold 7,089,144 Allergan plc shares in Q2 2020, an estimated $1.26B.
  • Renaissance Technologies first reported a position in Allergan plc in Q2 2013 and held it in 21 quarters.
  • Renaissance Technologies's Allergan plc position peaked at $1.26B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.